Recognizing Recovery Partners for Their Commitment to Excellence in Advancing Global Allograft Needs
Edison, NJ (March 27, 2025) — MTF Biologics proudly announced the recipients of its 2024 Technical Awards, honoring outstanding achievements in tissue recovery throughout 2024. The awards were presented on March 27, 2025.
These annual awards highlight the dedication and expertise of MTF Biologics’ Recovery Partners, whose exceptional work ensures the availability of high-quality allografts to patients worldwide.
“We are honored to recognize our Recovery Partners for their remarkable contributions in 2024,” said Mike Real, Vice President of Procurement at MTF Biologics. Their commitment to quality and innovation in tissue recovery sets the standard across our industry, helping to make life-changing tissue transplants possible for patients everywhere.
2024 Technical Award Honorees
Golden Glove Award - for excellence in sterile recovery of allografts:
Golden Graft Award - for superior surgical technique in skin allograft recovery:
Golden Hourglass Award - for excellence in timely donor release facilitation:
Trinity Award - for excellence in hemipelvis recovery and low bioburden rates supporting Trinity allografts:
Knee En-Bloc Award - for excellence in osteochondral allograft recovery, including en-bloc recovery rates, bioburden, and timely donor chart release:
Make it Happen Award - for meeting demand in specialized allograft recovery:
DonorNetwork West (Radius and Ulnar Recovery)
Lifebanc (Costal Cartilage Recovery)
Midwest Transplant Network (Costal Cartilage Recovery)
NJ Sharing Network (Radius and Ulnar Recovery)
Emerald Award of Excellence - for achieving best practice levels throughout 2024 in key performance metrics:
Emerald Award of Excellence with Distinction - for achieving best practice levels in all four quarters of 2024:
Platinum Partner Award - for top overall performance across all technical recovery categories:
MTF Biologics also recognized all Recovery Partners who met best practice benchmarks in any key performance area during 2024. Their collective efforts play a critical role in honoring the gift of donation and helping MTF Biologics deliver high-quality allografts to those in need.
About MTF Biologics
MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. It provides unmatched service, resources, and expertise to donors and their loved ones who give the gift of donation, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists.
The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized screening, coordination, and communications services to organ transplant centers, organ, tissue, and eye procurement organizations, and the hospitals and patients that they serve. Its sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation) expands its reach to patients across the globe. For more information, visit www.mtfbiologics.org.
Media Contact
Aleksa Loch
Email: aleksa.loch@finnpartners.com